Highlights from ASH 2024 by Rahul Banerjee
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition was held from December 7th-10th, 2024, at the San Diego Convention Center in San Diego, California.
The ASH annual meeting served as a major gathering for hematology professionals, attracting over 28,000 attendees, including clinicians, scientists, and researchers from across the globe. This meeting was the world’s largest and most comprehensive hematology event of the year.
With hundreds of sessions covering the latest trends in hematology, ASH provided attendees with numerous opportunities to engage with cutting-edge research and developments. Education Program sessions featured didactic presentations, panel discussions, and interactive question-and-answer segments with all the speakers. The event stood out as the premier gathering for hematology professionals worldwide.
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, Shared some highlights from the Conference:
Last investigator meeting for our Velcade reduction consortium
“ASH24 one last investigator meeting for our Velcade reduction consortium are always a pleasure to work with my partner in crime Gurbakhash Kaur.“
US myeloma immunotherapy consortium has grown
“The US myeloma immunotherapy consortium has grown and we even have our own logo now – plus 4 orals and 4 posters at ASH24!
Thanks Surbhi Sidana, Krina Patel, Doris Hansen for continuing to be our fearless leaders behind the scenes.”
Doris Hansen presenting the most sophisticated analysis
“ASH24 and the best for last! Our fearless US MM consortium leader Doris Hansen presenting the most sophisticated analysis of cilta-cel vs ide-cel in RW practice I’ve ever seen! Yes, an RCT will be ideal – but will never happen this decade.
So what do our current data show?”
ASH24 and the latest and greatest down with dex abstract
“ASH24 and the latest and greatest down with dex abstract in myeloma yet! Congrats Dr. Manier et al for excellent IFM 2017-03 study! Dara WAY more important than dex in MM – survival benefit with DR vs Rd. Default with dex should be to stop after 2 months!”
“ASH kudos to ASH for raising the most fit hematologists the world has ever known.”
“I’ve been ASH’d and am laughing out loud – the ASH’s social media team has been on fire this ASH24!!
Well played, ASH, well played… I’m glad you saw my tweet about the ASH flag!”
“ASH kudos to Ciara Freeman for leading one of the most exciting orals of ASH24! Phase 2 trial of anito-cel as likely next BCMA CAR-T to get approved.
Setting stage – reminding us how different the CAR looks and how study was designed. Only 1 out of 118 manuf failures!”\
Myeloma field don’t squint at PET images
“ASH24 we in myeloma field don’t squint at PET images as much as our lymphoma colleagues… maybe soon we’ll have to! FASCINATING radiolabeling of cilta-cel in vivo for EMD MM by Harrison et al. Caught on camera: CAR T cells accumulating around EMD trying to break in.”
“ASH24 fascinating to see Omar Nadeem, Irenem Ghobrial and colleagues pull it off again!
Last year teclistamab, this year cilta-cel in high-risk SMM. 100% MRD-neg, very likely a curative approach to these patients. More follow-up and careful risk-benefit discussions needed!”
Doris Hansen co-leading our US myeloma consortium
“ASH24 thanks Doris Hansen for co-leading our US myeloma consortium – we are grateful to you Surbhi Sidana, Krina Patel for your wisdom! Doris isn’t on Twitter but she’s somehow always looking over my shoulder when I’m live-tweeting.”
“ASH24 off to plane now – my heart is more full than all the 24-hour urine jugs in the world! Thanks to colleagues, incl. MM patient advocates, for great feedback – and BMT CTN, ASH for opportunity.
And of course mentor Nina Shah who first pitched this to me in 2019!”
“ASH24 that’s a wrap! Thanks ASH for encouraging these conversations as always (>25K tweets!) – Twitter is always where I learn the most from my colleagues and realize which sessions I missed.
The Leukemia and Lymphoma Society – looking forward to ‘competing’ again next year!”
Highlights from Day 1 of ASH 2024.
Highlights from Day 2 of ASH 2024.
Highlights from Day 3 of ASH 2024.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023